NPRL3

NPR3 like, GATOR1 complex subunit, the group of GATOR1 subcomplex

Basic information

Region (hg38): 16:84271-138677

Previous symbols: [ "C16orf35" ]

Links

ENSG00000103148NCBI:8131OMIM:600928HGNC:14124Uniprot:Q12980AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • familial focal epilepsy with variable foci (Supportive), mode of inheritance: AD
  • focal epilepsy (Definitive), mode of inheritance: AD
  • epilepsy, familial focal, with variable foci 3 (Moderate), mode of inheritance: AD
  • epilepsy, familial focal, with variable foci 3 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Epilepsy, familial focal, with variable foci 3ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic26285051; 26505888; 27173016

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPRL3 gene.

  • Epilepsy,_familial_focal,_with_variable_foci_3 (799 variants)
  • not_provided (245 variants)
  • Inborn_genetic_diseases (60 variants)
  • NPRL3-related_disorder (20 variants)
  • not_specified (17 variants)
  • Seizure (7 variants)
  • Epilepsy,_familial_focal,_with_variable_foci_1 (2 variants)
  • Familial_focal_epilepsy_with_variable_foci (1 variants)
  • Epilepsy (1 variants)
  • Intellectual_disability (1 variants)
  • Autosomal_dominant_nocturnal_frontal_lobe_epilepsy (1 variants)
  • Focal_epilepsy (1 variants)
  • Familial_temporal_lobe_epilepsy_2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPRL3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001077350.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
9
clinvar
163
clinvar
3
clinvar
175
missense
2
clinvar
3
clinvar
342
clinvar
26
clinvar
4
clinvar
377
nonsense
28
clinvar
9
clinvar
1
clinvar
38
start loss
0
frameshift
44
clinvar
10
clinvar
11
clinvar
1
clinvar
1
clinvar
67
splice donor/acceptor (+/-2bp)
9
clinvar
28
clinvar
2
clinvar
2
clinvar
41
Total 83 50 365 192 8

Highest pathogenic variant AF is 0.000012945

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPRL3protein_codingprotein_codingENST00000399953 1454587
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1900.81072912396971247050.924
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.842453400.7200.00002163661
Missense in Polyphen6593.9760.691661084
Synonymous-0.1521491471.020.000009981131
Loss of Function3.42624.10.2490.00000118281

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American2.001.89
Ashkenazi Jewish1.000.928
East Asian1.000.955
Finnish1.000.934
European (Non-Finnish)1.000.913
Middle Eastern1.000.955
South Asian1.000.956
Other1.000.917

dbNSFP

Source: dbNSFP

Function
FUNCTION: As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway. {ECO:0000269|PubMed:23723238}.;
Disease
DISEASE: Epilepsy, familial focal, with variable foci 3 (FFEVF3) [MIM:617118]: An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions, including the temporal, frontal, parietal, and occipital lobes. Seizure types commonly include temporal lobe epilepsy, frontal lobe epilepsy, and nocturnal frontal lobe epilepsy. Some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. A subset of patients have structural brain abnormalities. Penetrance of the disorder is incomplete. {ECO:0000269|PubMed:26285051, ECO:0000269|PubMed:26505888, ECO:0000269|PubMed:27173016}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
mTOR signaling pathway - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.147

Haploinsufficiency Scores

pHI
0.164
hipred
N
hipred_score
0.481
ghis
0.422

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.731

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nprl3
Phenotype
immune system phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
ventricular septum development;negative regulation of TOR signaling;cellular response to amino acid starvation;aorta morphogenesis;TORC1 signaling;positive regulation of GTPase activity;cardiac muscle tissue development;roof of mouth development;regulation of autophagosome assembly
Cellular component
lysosomal membrane;GATOR1 complex
Molecular function
GTPase activator activity;protein binding